Effectiveness of acupoint stimulation to increase bone mineral density in postmenopausal women with low bone mass: A randomized controlled trial
Phase 1
Not yet recruiting
- Conditions
- Postmenopausal osteoporosis
- Registration Number
- ITMCTR1900002273
- Lead Sponsor
- WenZhou Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
1. Postmenopausal (surgical or natural, for more than a year and below 5 years) women;
2. According to the World Health Organization (WHO), osteopenia is defined as a Bone Mass Density (BMD) T score between -1.0 and -2.5 SD;
3. Patients with informed consent.
Exclusion Criteria
1. Patients complicated with clinically significant cardiovascular, renal, hepatic disease;
2. Patients with mental illness or without self-knowledge;
3. Patients with secondary osteoporosis;
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie acupoint stimulation's effect on bone mineral density in postmenopausal osteoporosis?
How does acupoint stimulation compare to bisphosphonates in improving bone mineral density for postmenopausal women with low bone mass?
Are there specific biomarkers that predict response to acupoint stimulation in postmenopausal osteoporosis patients?
What are the potential adverse events associated with acupoint stimulation for treating postmenopausal osteoporosis?
What combination therapies are being explored alongside acupoint stimulation for enhancing bone mineral density in postmenopausal women?